The toxicity of partially hydrolyzed guar gum (PHGG, average molecular weight 20,000) was evaluated in a 28-day, repeated oral dosing study (gavage) in rats at doses of 0, 500, and 2,500 mgkdday and in Salmonella typhimuriurn, with and without metabolic activation. PHGG did not elicit any signs of toxicity at the doses tested. PHGG was not mutagenic. Key Words:
Guar gum (CAS #9000-30-0), a gel-forming polysaccharide derived from the Indian cluster bean Cyanopsis tetragonolobus, is used worldwide in the food industry as a thickener and emulsion stabilizer. Graham et al. (1981) fed guar gum to rats at a level of 1 .O, 2.0,4.0,7.5, or 15.0% in the diet for 91 days and found that weight gains in female rats of all the treated groups and in male rats on the 7.5 and 10.0% dietary levels were significantly reduced. There were no other compound-related effects. Guar gum decreases the utilization efficiency of protein (Poksay and Schneeman, 1983) and lipids (Simons et al., 1982;  Vahouny et al., 1987) . This effect may be due to its high viscosity; when dissolved in water guar gum results in a slower gastric emptying (Shah et al., 1986) , interfering with the digestion and absorption of nutrients (Ikegami et al., 1990) . Guar gum did not elicit measurable mutagenic responses in the hostmediated assay using Salmonella (Stanford Research Institute, 1972) . Guar gum was fed as a dietary admixture to F344 rats and B6C3F mice. Guar gum was not carcinogenic in either species or sex (National Toxicological Program, 1982) .
Prehydrolyzed guar gum is metabolized by the colonic microflora as is intact guar gum, with the products of metabolism being the same, since in both cases metabolism is based on the fermentation of mannose and galactose (Nyman and Asp, 1982) .
Partially hydrolyzed guar gum (PHGG) is proposed for use in foods to provide several technical effects (e.g., emulsification, foam stabilization, moisture retention, and texture improvement). The absence of viscous properties, which limit the levels of addition of guar gum to foods, will permit addition of higher levels of PHGG to food products in complete liquid tube feeding formulas. It could be incorporated into liquid diets without a significant increase in viscosity and would allow the option of using soluble fermentable fiber in tube feeding formulas.
The present study was conducted to evaluate the repeated dosing toxicity of PHGG in rats and the mutagenic potential in Salmonella.
METHODS

Materials
PHGG, (Sunfiber; Taiyo Kagaku) with an average molecular weight [determined by high-performance liquid chromatography technique (Ide et al., 1991) ] of 20,000 (range: 1,000-1100,000) was the test material. It was prepared with use of a commercial preparation of p-D-endo mannanase from Asperigillus niger (Ueda Chemical Industrial).
Oral Repeated Dosing
Four-week-old male and female Sprague-Dawley rats (Charles River Japan) were acclimatized for 13 days prior to testing. Five rats per sex per group were used, The rats were housed individually in a barrier-system animal room and were allowed food (Oriental Yeast Co., Ltd.) and water ad libitum. Rats were administered PHGG solution (10 ml/kg) by gavage daily for 28 days at 0, 500, or 2,500 mg/kg. These doses are multiples of anticipated daily human consumption of PHGG of 5 g (100 mg/kg). Deaths were recorded and clinical observations were made twice a day, body weights were measured twice a week, and food consumption once a week.
Ophthalmologic examinations were performed prior to initiation of the study and prior to sacrifice, on three male and female rats randomly selected from each group. The eyes were dilated with a mydriatic agent (Mydrin-P;Santen Pharmaceutical). The ocular fundi were observed microscopically with use of a retinal camera (RC-2 Model 621, Kowa).
Rats were placed in metabolism cages to facilitate collection of urine. Urinalysis consisted of determining color, pH, occult blood, protein, ketone bodies, urobilinogen, and bilirubin (Ames Clinitek test paper; Miles-Sankyo), epithelial cells, erythrocytes, leukocytes, blood agglutination, cast and crystals for 3-h urine and specific gravity (Uripet; Nihon Optics) for 21-h urine.
Blood was collected by cannulation from the abdominal aorta under pentobarbital anesthesia (Tokyo Kasei Kogyou) at sacrifice. Hematological evaluation included hemoglobin and hematocrit and erythrocyte, total and differential leukocyte, and platelet counts (Multiple Automatic Blood Counter, Sysmex E-2000; Toa Medical Electronics). Serum clinical chemistry tests were performed to determine concentrations of Na+ , K + (FLAME-30C; Jasco Medical Instruments), C1-(Chlor meter C 200AP; Joko), calcium, iron, inorganic phosphate (Pi), glucose, urea nitrogen (BUN), creatinine, total bilirubin, total protein, albumin, globulin, total cholesterol, triglycerides, and activities of glutamic-oxalacetic transaminase (GOT), glutamic-pyruvic transaminase (GFT), alkaline phosphatase (AU 500: Olympus Optical) Albumin and a-1, a-2, p-3, p-and y-globulin were measured by electrophoresis.
At necropsy, following gross examination, brain, pituitary, heart, lungs, thymus, liver, spleen, kidneys, adrenals, salivary glands, male reproductive organs (testicles, prostate gland), and female reproductive organs (ovaries, uterus) were removed and weighed. These same tissues were fixed in 10% neutral buffered formalin, embedded in paraffin, and sliced to prepare specimens stained with hematoxylin-eosin, which were examined histologically.
Mutagenicity Assay
Salmonella typhimurium, strains TA98 and TA 100, were obtained from the National Institute of Hygienic Sciences. TAl00 is a typical strain in which basepair substitution abnormalities are detected, and TA98 is a typical strain in which frame-shift abnormalities are detected. Mutagenicity assay was performed by the method of Ames et al. (1979, with or without adding S9 mixture (Oriental Yeast).
PHGG was dissolved in distilled water for injection (Otsuka Pharmaceutical Factory) at concentrations of 50, 100, 500, 1,OOO, and 5,000 Fg/plate. 2-Aminoanthracene (2AA; Nakalai Tesque) and 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide (AF-2; Wako Pure Chemical Industries) were used as positive controls and were dissolved in dimethyl sulfoxide (DMSO; Dojindo Laboratories). PHGG, 2AA (0.01 Fg/plate in TAl00 strain, 0.1 pg/plate in TA98 strain) and AF-2 (1 .O p,g/plate in TAl00 strain, 0.5 &plate TA98 strain) were pre-incubated with or without S9 mixture for 20 min at 37°C. Revertant colonies were scored after incubation for 48 h at 37°C. 
Statistical Analysis of Results
Significant difference between the control group and each PHGG group was determined with use of a multiple comparison test. A homoscedastic test was performed with use of the Bartlett method, and an analysis of variance was performed by the Dunnett method (Dunnett et al., 1964) .
This study was conducted in accordance with Notification No. 313 of the Pharmaceutical Affairs Bureau, Ministry of Health and Welfare "On Standards for Good Laboratory Practice for the Study of Drug Safety."
RESULTS
Repeated-Dosing Study
There were no deaths during the experimental period. There were no statistically significant compound-related and dose-dependent effects on body weight gain, food consumption (Tables 14), or general behavior. Statistically significant, compound-related and dose-dependent effects were not observed with any of the parameters evaluated including hematology, serum chemistries, urinalyses, oph- thalmology, gross necropsy findings, organ weights and ratios, and histopathological findings.
Mutagenicity
The positive control substances showed a definite increase in the number of revertant colonies with respect to each strain. The number of revertant colonies with PHGG with or without metabolic activation did not show a twofold increase or more compared with the control with either bacterial strain, and a dosedependent effect was not observed.
DISCUSSION
In the repeated-dosing study, no deaths and no changes were observed in the general condition of the rats. No effects due to the administration of PHGG were observed on body weight, food consumption, urinalysis, or ophthalmologic or histopathologic examinations. These results suggest that the administration of PHGG to male and female rats under the conditions of this study did not elicit compound-related adverse effects. It is concluded that the no adverse effect level (NOAEL) of PHGG is greater than 2,500 m a g . PHGG was not mutagenic in Salmonella ryphimuriurn TAlOO or TA98 either with or without metabolic activation.
